Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about disclosure

10 Jul 2020 Evaluate

Aurobindo Pharma has informed that exchange has received disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 10, 2020 for RPR Sons Advisors, and P. Suneela Rani (jointly holding).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..